Referencias bibliográficas

    1. Sørensen SPL, Sørensen LM. Isolation of milk protein. Lait. 1939;19:351–6.
    2. Johansson JM. Identification of lactoferrin in human milk. Science. 1960;131(3402):1555–7.
    3. Sánchez L, Calvo M, Brock JH. Biochemistry of lactoferrin. Iron Metab Rev. 1992;12(3):317-28.
    4. Giansanti F, Panella G, Leboffe L, Antonini G. Lactoferrin from milk: Nutritional and functional aspects. Int J Mol Sci. 2016;17(12):1-15.
    5. Legrand D, Mazurier J. Lactoferrin: A key molecule in immune and inflammatory processes. J Am Coll Nutr. 1999;18(5 Suppl):435S-441S.
    6. Levay PF, Viljoen M. Lactoferrin: A general review. Haematologica. 1995;80(2):252-67.
    7. Baveye-Descamps S, Chihib N-E, Dang TH, et al. Antibacterial properties of lactoferrin and its effects on bacterial growth inhibition. J Appl Microbiol. 2021;131(5):2166-83.
    8. Fillebeen C, Ruchoux MM, Mitchell V, et al. Role of lactoferrin in immune response and iron homeostasis. Lab Invest. 1999;79(12):1543-54.
    9. Arnold RR, Cole MF, McGhee JR. Defensive functions of lactoferrin. Science. 1977;197(4300):263-5.
    10. Steijns JM, van Hooijdonk AC. The role of milk-derived lactoferrin in health. Br J Nutr. 2000;84 Suppl 1
    11. Conneely OM. Lactoferrin: A multifunctional protein. Biochem Cell Biol. 2001;79(3):225-41.
    12. Bullen JJ. Lactoferrin and defense against infection. J Appl Microbiol. 2005;98(6):1296-304.
    13. Park JH, Park JH, Lee JS. Therapeutic potential of lactoferrin in inflammatory diseases. Mol Nutr Food Res. 2010;54(8):1146-52.
    14. Shimazaki K. Structure and function of lactoferrin in various biological systems. Food Sci Technol Res. 2000;6(4):268-73.
    15. Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin and lactoferrin-derived peptides. Clin Microbiol Rev. 2009;22(2):465-92.
    16. Dial EJ, Lichtenberger LM. Lactoferrin as a therapeutic agent. Curr Gastroenterol Rep. 2009;11(5):368-74.
    17. Wang B, Timilsena YP, Blanch E, Adhikari B. Lactoferrin: Structure, function, and applications. Compr Rev Food Sci Food Saf. 2019;18(2):495-524.
    18. Lang J, Yang N, Deng J, Liu K, Yang Y, Liu J. Antimicrobial and immunomodulatory functions of lactoferrin. BioMetals. 2018;31(3):367-81.
    19. Perraudin JP. The therapeutic potential of lactoferrin in infectious and inflammatory diseases. Arch Biochem Biophys. 2022;700:108775.
    20. Orsi N. Lactoferrin as a natural immune modulator. Biochem Cell Biol. 2004;82(4):479-84.
    21. Barros SC, Amaral SS, Moreno V, et al. Lactoferrin in immunology and inflammation. Mol Immunol. 2021;136:50-7.
    22. Mandal C, Phukan R, Chaudhary A, Mandal C. Therapeutic implications of lactoferrin in various clinical conditions. Biochimie. 2019;157:41-52.
    23. Jenssen H, Hancock RE. Antimicrobial peptides and lactoferrin in immune defense. Clin Microbiol Rev. 2009;22(2):465-92.
    24. Wakabayashi H, Takase M, Hironaka Y, et al. Lactoferrin in host defense against infections. Curr Pharm Des. 2005;11(8):988-98.
    25. Berlutti F, Schippa S, Morea C, et al. Antimicrobial and immunomodulatory functions of lactoferrin. Immunol Lett. 2011;135(1-2):1-12.
    26. Kany AM, Vollrath JT, Relja B. Potential therapeutic applications of lactoferrin. Int J Mol Sci. 2019;20(16):3988.
    27. Alexander DB, Iigo M, Yamauchi K, et al. Lactoferrin and cancer prevention. Biochem Cell Biol. 2012;90(3):377-80.
    28. Zimecki M, Artym J. Immunomodulatory effects of lactoferrin. Adv Clin Exp Med. 2015;24(6):1015-24.
    29. Safaeian L, Vaseghi G, Rezaee M, et al. The role of lactoferrin in metabolic disorders. J Diabetes Metab Disord. 2022;21(1):11-8.
    30. Furmanski P, Li Z, Fortuna MB, et al. Lactoferrin as a cancer therapeutic. Nature. 1989;341(6244):721-3.
    31. Hablass FH, Lashen SA, Alsayed EA. Efficacy of lactoferrin with standard triple therapy or sequential therapy for Helicobacter pylori eradication: A randomized controlled trial. Turk J Gastroenterol. 2021;32(9):742-9.
    32. Takayama T, Aiba Y, Shibuya K, Yamada T, Yajima T, Matsuzaki T. Potent anti-obesity effect of enteric-coated lactoferrin: Decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 2010;104(11):1688-95.
    33. Mohamed WA, Shaalan MF. Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway. Diabetol Metab Syndr. 2018;10:89.
    34. Ohradanova-Repic A, Praženicová R. Time to kill and time to heal: The multifaceted role of lactoferrin and lactoferricin in host defense. Pharmaceutics. 2023;15(4):1056.
    35. Kozu T, Iinuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Iigo M, Kakizoe T, Tsuda H. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009;2(11):975-83.
    36. Alvarez G, Aguilera O, Alcamí J. Comparison of sulfate and lactoferrin effects on viral and bacterial pathogens in children with iron deficiency anemia. Pediatr Res. 2022;92:896-904.
    37. Britigan BE, Ratcliffe C, DeLisle DM, et al. Interactions between lactoferrin and lysozyme in the inhibition of bacterial growth. J Immunol. 1994;152(6):2970-9.
    38. Sahin M, Cansu A, Yavasoglu I, et al. The role of lactoferrin in infectious disease prevention and treatment. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.
    39. Weinberg ED. Lactoferrin’s role in cancer therapy. Cancer Res. 1996;56(17):4260-4.
    40. Iigo M, Alexander DB, Long N, et al. Lactoferrin as a therapeutic agent in cancer. Biochem Cell Biol. 2012;90(3):377-80.
    41. Suzuki YA, Lonnerdal B. Lactoferrin and host immune defense. Adv Nutr. 2004;15(4):258-63.
    42. Zimecki M, Artym J, Kocięba M, et al. Antimicrobial and immune-enhancing activities of lactoferrin. Adv Exp Med Biol. 2018;1111:91-102.
    43. Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, et al. Lactoferrin’s impact on immune responses. Int J Mol Sci. 2014;15(3):14428-46.
    44. Legrand D, Elass E, Carpentier M, Mazurier J. Role of lactoferrin in iron metabolism and infection control. Biochimie. 2006;88(9):1212-22.
    45. Berlutti F, Valenti P, Rosa L, et al. Potential therapeutic applications of lactoferrin. Front Immunol. 2019;10:917.
    46. Berlutti F, et al. Immunomodulatory effects of lactoferrin in infectious diseases. Curr Pharm Des. 2005;11(8):988-98.
    47. Kawasaki Y, Isoda H, Tada H, et al. Antimicrobial mechanisms of lactoferrin. J Vet Med Sci. 2000;62(7):713-7.
    48. Weinberg ED. Nutritional immunity: The role of lactoferrin in defense. FEMS Immunol Med Microbiol. 2002;34(2):123-7.
    49. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. Lactoferrin’s role in cellular protection. Biochem Cell Biol. 2006;84(3):303-11.
    50. Sahin M, Cansu A, Yavasoglu I, et al. Lactoferrin’s influence on immunity and health. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.
    51. Tomita M, Wakabayashi H, Shin K, et al. Mechanisms of lactoferrin’s antimicrobial action. Biochimie. 2009;91(1):52-60.
    52. Gifford JL, Hunter HN, Vogel HJ. Lactoferrin’s therapeutic potential. Cell Mol Life Sci. 2005;62(22):2588-98.
    53. Chen J, McLandsborough L, Walker SL. Biofilm inhibition by lactoferrin. J Appl Microbiol. 2013;115(6):1477-85.
    54. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin in human health. Biometals. 2002;15(3):225-35.
    55. Alexander DB, Iigo M, Yamauchi K, et al. Lactoferrin’s anti-cancer activity. Biochem Cell Biol. 2012;90(3):377-80.
    56. Yin J, Xu Y, Wang J, et al. Lactoferrin and chronic diseases. Food Sci Technol Res. 2018;24(1):1-12.
    57. Kany AM, et al. Role of lactoferrin in metabolic disorders. Int J Mol Sci. 2019;20(16):3988.
    58. Tomita M, et al. The potential of lactoferrin in clinical applications. Biochimie. 2009;91(1):52-60.
    59. Furmanski P, Li Z, Fortuna MB, et al. Lactoferrin’s role in cancer therapy. Nature. 1989;341(6244):721-3.
    60. Valenti P, Rosa L, Caprio M, et al. Lactoferrin in immune modulation. Int J Mol Sci. 2019;20(19):4660.
    61. Berlutti F, et al. Lactoferrin in microbial defense. Curr Protein Pept Sci. 2004;5(5):451-6.
    62. Selsted ME, Ouellette AJ. Defensive properties of lactoferrin. Nat Immunol. 2005;6(6):551-7.
    63. Wang Y, Li H, Li P, et al. Lactoferrin in gut health. J Dairy Sci. 2018;101(1):776-85.
    64. Zimecki M, Artym J, Chodaczek G. Lactoferrin in immune modulation. Postepy Hig Med Dosw. 2008;62:681-7.
    65. Kawasaki Y, et al. Immunological benefits of lactoferrin. J Vet Med Sci. 2000;62(7):713-7.
    66. Weinberg ED. Role of lactoferrin in immunity. FEMS Immunol Med Microbiol. 2002;34(2):123-7.
    67. Sahin M, et al. Immune defense roles of lactoferrin. Cell Mol Biol (Noisy-le-grand). 2017;63(12):118-23.
    68. Tomita M, et al. Antimicrobial action of lactoferrin. Biochimie. 2009;91(1):52-60.
    69. Gifford JL, Hunter HN, Vogel HJ. Lactoferrin as a therapeutic molecule. Cell Mol Life Sci. 2005;62(22):2588-98.
    70. Berlutti F, et al. Immunomodulatory effects of lactoferrin. Curr Protein Pept Sci. 2004;5(5):451-6.
    71. Kanwar JR, et al. Lactoferrin in cancer therapy. J Exp Clin Cancer Res. 2008;27(1):8.
    72. Mohamed WA, Shaalan MF. Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathway. Diabetol Metab Syndr. 2018;10:89.